The DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
Cognitive Dysfunction in Multiple Sclerosis
Open accessAbstract
In Multiple Sclerosis (MS) prevalence studies of community and clinical samples, indicate that 45-60% of patients are cognitively impaired. These cognitive dysfunctions have been traditionally described as heterogeneous, but more recent studies suggest that there is a specific pattern of MS-related cognitive dysfunctions. With the advent of disease-modifying medications for MS and emphasis on early intervention and treatment, detection of cognitive impairment at its earliest stage becomes particularly important. In this review the authors address: the cognitive domains most commonly impaired in MS (memory, attention, executive functions, speed of information processing, and visual-spatial abilities); the pathophysiological mechanism implied in MS cognitive dysfunction and correlated brain MRI features; the importance of neuropsychological assessment of MS patients in different stages of the disease and the influence of its course on cognitive performance; the most used tests and batteries for neuropsychological assessment; therapeutic strategies to improve cognitive abilities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria
Polman, C. H., Reingold, S. C., Banwell, B., Clanet, M., Cohen, J. A., Filippi, M., Fujihara, K., Havrdova, E., Hutchinson, M., Kappos, L., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22366 · Cited by 9,802
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
Polman, C. H., Reingold, S. C., Edan, G., Filippi, M., Hartung, H., Kappos, L., Lublin, F. D., Metz, L. M., McFarland, H. F., O'Connor, P. W., et al. (2005) · Annals of Neurology · doi:10.1002/ana.20703 · Cited by 5,017
Basser, P. J., & Pierpaoli, C. (1996) · Journal of Magnetic Resonance, Series B · doi:10.1006/jmrb.1996.0086 · Cited by 4,306
A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
Polman, C. H., O'Connor, P. W., Havrdova, E., Hutchinson, M., Kappos, L., Miller, D. H., Phillips, J. T., Lublin, F. D., Giovannoni, G., Wajgt, A., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa044397 · Cited by 3,386
Cognitive dysfunction in multiple sclerosis.: I. Frequency, patterns, and prediction
Rao, S. M., Leo, G. J., Bernardin, L., & Unverzagt, F. (1991) · Neurology · doi:10.1212/wnl.41.5.685 · Cited by 2,110
Cognitive impairment in multiple sclerosis
Chiaravalloti, N. D., & DeLuca, J. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70259-x · Cited by 2,088
Natalizumab plus Interferon Beta-1a for Relapsing Multiple Sclerosis
Rudick, R. A., Stuart, W. H., Calabresi, P. A., Confavreux, C., Galetta, S. L., Radue, E.-W., Lublin, F. D., Weinstock-Guttman, B., Wynn, D. R., Lynn, F., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa044396 · Cited by 1,344
Diagnostic criteria for multiple sclerosis
Poser, C. M., & Brinar, V. V. (2001) · Clinical Neurology and Neurosurgery · doi:10.1016/s0303-8467(00)00125-6 · Cited by 1,283
Kappos, L. (1998) · The Lancet · doi:10.1016/s0140-6736(98)10039-9 · Cited by 936
Cognitive dysfunction in multiple sclerosis.: II. Impact on employment and social functioning
Rao, S. M., Leo, G. J., Ellington, L., Nauertz, T., Bernardin, L., & Unverzagt, F. (1991) · Neurology · doi:10.1212/wnl.41.5.692 · Cited by 890
Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS)
BENEDICT, R. H. B., COOKFAIR, D., GAVETT, R., GUNTHER, M., MUNSCHAUER, F., GARG, N., & WEINSTOCK-GUTTMAN, B. (2006) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617706060723 · Cited by 798
Cortical lesions in multiple sclerosis
Kidd, D., Barkhof, F., McConnell, R., Algra, P. R., Allen, I. V., & Revesz, T. (1999) · Brain · doi:10.1093/brain/122.1.17 · Cited by 766
Minimal Neuropsychological Assessment of MS Patients: A Consensus Approach
Benedict, R. H. B., Fischer, J. S., Archibald, C. J., Arnett, P. A., Beatty, W. W., Bobholz, J., Chelune, G. J., Fisk, J. D., Langdon, D. W., Caruso, L., et al. (2002) · The Clinical Neuropsychologist · doi:10.1076/clin.16.3.381.13859 · Cited by 659
Calabrese, M., Agosta, F., Rinaldi, F., Mattisi, I., Grossi, P., Favaretto, A., Atzori, M., Bernardi, V., Barachino, L., Rinaldi, L., et al. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.174 · Cited by 555
Basser, P. J., & Pierpaoli, C. (2011) · Journal of Magnetic Resonance · doi:10.1016/j.jmr.2011.09.022 · Cited by 551
Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology.
Geurts, J. J. G., Bø, L., Pouwels, P. J. W., Castelijns, J. A., Polman, C. H., & Barkhof, F. (2005) · PubMed · Cited by 407
Cognition in multiple sclerosis
Langdon, D. W. (2011) · Current Opinion in Neurology · doi:10.1097/wco.0b013e328346a43b · Cited by 403
Benefit of interferon β-1a on MSFC progression in secondary progressive MS
Cohen, J. A., Cutter, G. R., Fischer, J. S., Goodman, A. D., Heidenreich, F. R., Kooijmans, M. F., Sandrock, A. W., Rudick, R. A., Simon, J. H., Simonian, N. A., et al. (2002) · Neurology · doi:10.1212/wnl.59.5.679 · Cited by 402
Neuropsychology of multiple sclerosis: A critical review
Rao, S. M. (1986) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/01688638608405173 · Cited by 387
Disconnection as a mechanism for cognitive dysfunction in multiple sclerosis
Dineen, R. A., Vilisaar, J., Hlinka, J., Bradshaw, C. M., Morgan, P. S., Constantinescu, C. S., & Auer, D. P. (2009) · Brain · doi:10.1093/brain/awn275 · Cited by 376
Kappos, L., Freedman, M. S., Polman, C. H., Edan, G., Hartung, H.-P., Miller, D. H., Montalbán, X., Barkhof, F., Radü, E.-W., Metzig, C., et al. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70237-6 · Cited by 369
Staffen, W., Mair, A., Zauner, H., Unterrainer, J., Niederhofer, H., Kutzelnigg, A., Ritter, S., Golaszewski, S., Iglseder, B., & Ladurner, G. (2002) · Brain · doi:10.1093/brain/awf125 · Cited by 330
Executive function in multiple sclerosis. The role of frontal lobe pathology
Foong, J. (1997) · Brain · doi:10.1093/brain/120.1.15 · Cited by 318
Neocortical volume decrease in relapsing–remitting MS patients with mild cognitive impairment
Amato, M. P., Bartolozzi, M. L., Zipoli, V., Portaccio, E., Mortilla, M., Guidi, L., Siracusa, G., Sorbi, S., Federico, A., & De Stefano, N. (2004) · Neurology · doi:10.1212/01.wnl.0000129544.79539.d5 · Cited by 318
Donepezil improved memory in multiple sclerosis in a randomized clinical trial
Krupp, L. B., Christodoulou, C., Melville, P., Scherl, W. F., MacAllister, W. S., & Elkins, L. E. (2004) · Neurology · doi:10.1212/01.wnl.0000142989.09633.5a · Cited by 300
Relation between MR abnormalities and patterns of cognitive impairment in multiple sclerosis
Rovaris, M., Filippi, M., Falautano, M., Minicucci, L., Rocca, M. A., Martinelli, V., & Comi, G. (1998) · Neurology · doi:10.1212/wnl.50.6.1601 · Cited by 296
Gray and white matter brain atrophy and neuropsychological impairment in multiple sclerosis
Sanfilipo, M. P., Benedict, R. H. B., Weinstock-Guttman, B., & Bakshi, R. (2006) · Neurology · doi:10.1212/01.wnl.0000201238.93586.d9 · Cited by 296
Fatigue and declines in cognitive functioning in multiple sclerosis
Krupp, L. B., & Elkins, L. E. (2000) · Neurology · doi:10.1212/wnl.55.7.934 · Cited by 292
Differences in cognitive impairment of relapsing remitting, secondary, and primary progressive MS
Huijbregts, S. C. J., Kalkers, N. F., de Sonneville, L. M. J., de Groot, V., Reuling, I. E. W., & Polman, C. H. (2004) · Neurology · doi:10.1212/01.wnl.0000129828.03714.90 · Cited by 277
Guidelines for Neuropsychological Research in Multiple Sclerosis
Peyser, J. M., Rao, S. M., LaRocca, N. G., & Kaplan, E. (1990) · Archives of Neurology · doi:10.1001/archneur.1990.00530010120030 · Cited by 264
Morgen, K., Sammer, G., Courtney, S. M., Wolters, T., Melchior, H., Blecker, C. R., Oschmann, P., Kaps, M., & Vaitl, D. (2006) · NeuroImage · doi:10.1016/j.neuroimage.2005.10.032 · Cited by 234
Sperling, R. A., Guttmann, C. R. G., Hohol, M. J., Warfield, S. K., Jakab, M., Parente, M., Diamond, E. L., Daffner, K. R., Olek, M. J., Orav, E. J., et al. (2001) · Archives of Neurology · doi:10.1001/archneur.58.1.115 · Cited by 219
Neuropsychological rehabilitation for multiple sclerosis
Rosti-Otajärvi, E. M., & Hämäläinen, P. I. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009131.pub3 · Cited by 217
Strober, L., Englert, J., Munschauer, F., Weinstock-Guttman, B., Rao, S., & Benedict, R. (2009) · Multiple Sclerosis Journal · doi:10.1177/1352458509106615 · Cited by 216
Piras, M. R. (2003) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.7.878 · Cited by 215
Kinsinger, S. W., Lattie, E., & Mohr, D. C. (2010) · Neuropsychology · doi:10.1037/a0019222 · Cited by 200
Cognitive Disturbances in Patients With Relapsing Remitting Multiple Sclerosis
Beatty, W. W., Goodkin, D. E., Monson, N., & Beatty, P. A. (1989) · Archives of Neurology · doi:10.1001/archneur.1989.00520460103020 · Cited by 200
Cognition in the early stage of multiple sclerosis
Schulz, D., Kopp, B., Kunkel, A., & Faiss, J. H. (2006) · Journal of Neurology · doi:10.1007/s00415-006-0145-8 · Cited by 194
Rao, S. M., Grafman, J., DiGiulio, D., & Mittenberg, W. (1993) · Neuropsychology · doi:10.1037//0894-4105.7.3.364 · Cited by 193
Bergendal, G., Fredrikson, S., & Almkvist, O. (2007) · European Neurology · doi:10.1159/000099158 · Cited by 184
Information Processing Efficiency in Patients with Multiple Sclerosis
Archibald, C. J., & Fisk, J. D. (2000) · Journal of Clinical and Experimental Neuropsychology · doi:10.1076/1380-3395(200010)22:5;1-9;ft686 · Cited by 184
On the nature of memory disturbance in multiple sclerosis
Rao, S. M., Leo, G. J., & Aubin-Faubert, P. S. (1989) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/01688638908400926 · Cited by 182
Parry, A. M. M. (2003) · Brain · doi:10.1093/brain/awg284 · Cited by 172
Neuropsychologic Status in Multiple Sclerosis After Treatment With Glatiramer
Weinstein, A., Schwid, S. I. L., Schiffer, R. B., McDermott, M. P., Giang, D. W., & Goodman, A. D. (1999) · Archives of Neurology · doi:10.1001/archneur.56.3.319 · Cited by 159
Pliskin, N. H., Hamer, D. P., Goldstein, D. S., Towle, V. L., Reder, A. T., Noronha, A., & Arnason, B. G. W. (1996) · Neurology · doi:10.1212/wnl.47.6.1463 · Cited by 150
Multicenter randomized clinical trial of donepezil for memory impairment in multiple sclerosis
Krupp, L., Christodoulou, C., Melville, P., SCHERL, W. F., Pai, L.-Y., Muenz, L. R., He, D., Benedict, R. H. B., Goodman, A. D., Rizvi, S., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e318218107a · Cited by 139
Nelson, F. M., Datta, S., Garcia, N., Rozario, N. L., Perez, F. I., Cutter, G., Narayana, P. A., & Wolinsky, J. S. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458511405561 · Cited by 122
Effects of donepezil on memory and cognition in multiple sclerosis
Christodoulou, C., Melville, P., SCHERL, W. F., MacAllister, W. S., Elkins, L. E., & Krupp, L. (2006) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.08.021 · Cited by 115
Sastre‐Garriga, J., Alonso, J., Renom, M., Arévalo, M. J., González, I., Galán, I., Montalbán, X., & Rovira, À. (2010) · Multiple Sclerosis Journal · doi:10.1177/1352458510389219 · Cited by 113
Multicenter randomized clinical trial of donepezil for memory impairment in multiple sclerosis
Wiebenga, O. T., Heilman, K. M., Krupp, L. B., Hulst, H. E., Kooi, E.-J., Killestein, J., Geurts, J. J. G., Williamson, J. B., Christodoulou, C., & Benedict, R. H. B. (2011) · Neurology · doi:10.1212/wnl.0b013e318239c242 · Cited by 112
Summers, M., Fisniku, L. K., Anderson, V. M., Miller, D., Cipolotti, L., & Ron, M. A. (2007) · Multiple Sclerosis Journal · doi:10.1177/1352458507082353 · Cited by 110
Memantine for cognitive impairment in multiple sclerosis: a randomized placebo-controlled trial
Lovera, J. F., Frohman, E. M., Brown, T., Bandari, D. S., Nguyen, L., Yadav, V., Stüve, O., Kármán, J., Bogardus, K., Heimburger, G., et al. (2010) · Multiple Sclerosis Journal · doi:10.1177/1352458510367662 · Cited by 105
Landrø, N. I., Celius, E. G., & Sletvold, H. (2003) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2003.10.012 · Cited by 104
Memory in multiple sclerosis: Contextual encoding deficits
Thornton, A. E., Raz, N., & Tucker, K. A. (2002) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617702813200 · Cited by 98
Cognitive dysfunctions in multiple sclerosis – a “multiple disconnection syndrome”?
Calabrese, P., & Penner, I. (2007) · Journal of Neurology · doi:10.1007/s00415-007-2006-5 · Cited by 89
Cognitive deficits in multiple sclerosis: a systematic review
Ferreira, M. L. B. (2010) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x2010000400029 · Cited by 77
Effects of Rivastigmine on Memory and Cognition in Multiple Sclerosis
Shaygannejad, V., Janghorbani, M., Ashtari, F., Afshar, H., & Zakizade, N. (2008) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100009148 · Cited by 76
Ranjeva, J., Audoin, B., Duong, M. V. A., Duong, M. V. A., Ibarrola, D., Sylviane Confort-gouny, A., Irina Malikova, A., Soulier, E., Viout, P., Ali‐Chérif, A., et al. (2005) · PubMed · Cited by 76
Cognitive and neurobehavioral features in multiple sclerosis
Arnett, P. A., & Strober, L. B. (2011) · Expert Review of Neurotherapeutics · doi:10.1586/ern.11.12 · Cited by 62
Functional magnetic resonance imaging and cognition at the very early stage of MS
Audoin, B., Duong, M. V. A., Irina Malikova, A., Sylviane Confort-gouny, A., Ibarrola, D., Cozzone, P. J., Pelletier, J., & Ranjeva, J. (2006) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.08.026 · Cited by 61
Pharmacological treatment for memory disorder in multiple sclerosis
He, D., Zhang, Y., Dong, S., Wang, D., Gao, X., & Zhou, H. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008876.pub3 · Cited by 56
Ranjeva, J., Audoin, B., Duong, M. V. A., Sylviane Confort-gouny, A., Irina Malikova, A., Viout, P., Soulier, E., Pelletier, J., & Cozzone, P. J. (2006) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.09.019 · Cited by 56
Reliability and validity of neuropsychological screening and assessment strategies in MS
Benedict, R. H. B., & Zivadinov, R. (2007) · Journal of Neurology · doi:10.1007/s00415-007-2007-4 · Cited by 56
Huolman, S., Hämäläinen, P. I., Vorobyev, V., Ruutiainen, J., Parkkola, R. K., Laine, T., & Hämäläinen, H. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458511412061 · Cited by 54
Executive function in Multiple Sclerosis
Satgunasingam, Y. (2003) · UCL Discovery (University College London) · Cited by 54
Assessment and rehabilitation of cognitive impairment in multiple sclerosis
Messinis, L., Kosmidis, M., Lyros, E., & Papathanasopoulos, P. (2010) · International Review of Psychiatry · doi:10.3109/09540261003589372 · Cited by 51
Cortical lesions and cognitive impairment in multiple sclerosis
Rinaldi, F., Calabrese, M., Grossi, P., Puthenparampil, M., de Perini, P., & Gallo, P. (2010) · Neurological Sciences · doi:10.1007/s10072-010-0368-4 · Cited by 50
Christodoulou, C., MacAllister, W. S., McLinskey, N., & Krupp, L. (2008) · CNS Drugs · doi:10.2165/00023210-200822020-00001 · Cited by 49
Diagnostics of cognitive dysfunctions in multiple sclerosis
Engel, C., Greim, B., & Zettl, U. K. (2007) · Journal of Neurology · doi:10.1007/s00415-007-2009-2 · Cited by 49
Cognitive rehabilitation in Multiple sclerosis
Brissart, H., Leroy, M., Morele, E., Baumann, C., Spitz, É., & Debouverie, M. (2012) · Neurocase · doi:10.1080/13554794.2012.701644 · Cited by 45
Classical immunomodulatory therapy in multiple sclerosis: how it acts, how it works
Mendes, A., & Sá, M. J. (2011) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x2011000400024 · Cited by 40
Self-citationNeuropsychological rehabilitation for multiple sclerosis
Rosti-Otajärvi, E. M., & Hämäläinen, P. I. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009131.pub2 · Cited by 39
Activity of attention related structures in multiple sclerosis patients
Nebel, K., Wiese, H., Seyfarth, J., Gizewski, E. R., Stude, P., Diener, H., & Limmroth, V. (2007) · Brain Research · doi:10.1016/j.brainres.2007.03.007 · Cited by 38
Cognitive Dysfunction in Multiple Sclerosis
Glanz, B. I., & Houtchens, M. K. (2012) · Wiley eBooks · doi:10.1002/9781119963714.ch10 · Cited by 32
Pharmacologic treatment for memory disorder in multiple sclerosis
He, D., Zhou, H., Guo, D., Hao, Z., & Wu, B. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008876.pub2 · Cited by 19
Remédiation cognitive dans la sclérose en plaques : revue de la littérature
Brissart, H., Daniel, F., Morele, E., Leroy, M., Debouverie, M., & Defer, G. L. (2010) · Revue Neurologique · doi:10.1016/j.neurol.2010.07.039 · Cited by 17
Kealey, S. M., Kim, Y., Whiting, W. L., Madden, D. J., & Provenzale, J. M. (2005) · Radiology · doi:10.1148/radiol.2362040014 · Cited by 15
Nonthyroidal illness syndrome in patients with subarachnoid hemorrhage due to intracranial aneurysm
Casulari, L. A., Mangieri, P., Naves, L. A., Suzuki, K., Ferreira, M., & Domingues, L. (2004) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x2004000100005 · Cited by 14
Cognitive dysfunction in multiple sclerosis: The effect of pharmacological interventions
Lyros, E., Messinis, L., Papageorgiou, S. G., & Papathanasopoulos, P. (2010) · International Review of Psychiatry · doi:10.3109/09540261003589455 · Cited by 10
Sá, M. J., Guimarães, J., Abreu, P., Mendes, A., & Souto, E. B. (2011) · Current Nanoscience · doi:10.2174/157341311794480318 · Cited by 7
Self-citationTreating cognitive deficits in multiple sclerosis
Doraiswamy, P. M., & Rao, S. M. (2004) · Neurology · doi:10.1212/01.wnl.0000146628.30692.15 · Cited by 7
Pharmacologic treatment for memory disorder in multiple sclerosis
He, D., Zhou, H., Guo, D., Hao, Z., & Wu, B. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008876 · Cited by 5
Cognitive deficits in multiple sclerosis
Grigoriadis, N. (2003) · Annals of General Hospital Psychiatry · doi:10.1186/1475-2832-2-s1-s15 · Cited by 3
Cognitive Dysfunction in Multiple Sclerosis
Cox, D., & Julian, L. J. (2005) · Humana Press eBooks · doi:10.1385/1-59259-855-2:091 · Cited by 2
Cognitive rehabilitation in multiple sclerosis
Langdon, D. W. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511781698.021 · Cited by 1
(2000) · doi:10.1002/1531-8249(200012)48:6
Cited by
Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis
Dutta, R., & Trapp, B. D. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.09.005 · Cited by 457
Brief International Cognitive Assessment for MS (BICAMS): international standards for validation
Benedict, R. H., Amato, M. P., Boringa, J., Brochet, B., Foley, F., Fredrikson, S., Hamalainen, P., Hartung, H., Krupp, L., Penner, I., et al. (2012) · BMC Neurology · doi:10.1186/1471-2377-12-55 · Cited by 411
The benefits of exercise training in multiple sclerosis
Motl, R. W., & Pilutti, L. A. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.136 · Cited by 394
Risk factors for and management of cognitive dysfunction in multiple sclerosis
Benedict, R. H. B., & Zivadinov, R. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.61 · Cited by 370
Devonshire, V., Lapierre, Y., Macdonell, R., Ramo‐Tello, C., Patti, F., Fontoura, P., Suchet, L., Hyde, R., Balla, I., Frohman, E. M., et al. (2011) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03110.x · Cited by 340
Metadata
- Authors
- Guimarães, J., & Sá, M. J.
- Venue
- Frontiers in Neurology
- Publisher
- Frontiers Media SA
- Published
- 2012
- Volume
- 3
- Pages
- 74-74
- ISSN
- 1664-2295 (ISSN-L)
- OpenAlex
- W2168649763
- Cited by
- 427
- References
- 87
- FWCI
- 49.67
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.